NewEdge Advisors’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-600
Closed -$14 3760
2022
Q4
$14 Buy
+600
New +$13.7K ﹤0.01% 3659

Other funds holding IBD

NewEdge Advisors's IBD Position: Q1 2023 in Review

NewEdge Advisors sold out of Inspire Corporate Bond ETF (IBD) in Q1 2023, closing a stake of 600 shares — an estimated $14 sold.

NewEdge Advisors first reported a position in IBD in Q4 2022 and held it in 1 quarter. The position peaked at $14 in Q4 2022. 51 funds tracked by Wall St. Rank hold IBD as of Q1 2023.

  • NewEdge Advisors reported no remaining Inspire Corporate Bond ETF position as of Q1 2023 after selling out during the quarter.
  • NewEdge Advisors sold 600 Inspire Corporate Bond ETF shares in Q1 2023, an estimated $14.
  • NewEdge Advisors first reported a position in Inspire Corporate Bond ETF in Q4 2022 and held it in 1 quarter.
  • NewEdge Advisors's Inspire Corporate Bond ETF position peaked at $14 in Q4 2022.
  • 51 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q1 2023.

Based on NewEdge Advisors's 13F filing for Q1 2023, filed 12 May 2023.